Dergiler / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 1

Changes in the Surgical Treatment Strategies for Nonsmall Cell Lung Cancer in the Past 20 Years: A Single-Center Experience

Sayfa
8–13
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Postoperative mortality has decreased, and the survival rate has increased.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVES: Nonsmall cell lung cancer (NSCLC) is a multifactorial disease, and differences in the characteristics of surgical patientsmay develop over the years.
📊
Temel Bulgular & Veri:This study aimed to evaluate the patients who underwent curative surgical resection for NSCLC in the past20 years at our center and analyze the changes in the treatment strategies based on demographics, surgical strategies, and histopathology.MATERIALS AND METHODS: In this retrospective single-center cohort study, 1995 patients who had undergone lobectomy, bilobectomy, or pneumonectomy for primary NSCLC from January 1997 to January 2017 were analyzed.
💡
Sonuç & Katkı:Postoperative mortality has decreased, and the survival rate has increased.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

OBJECTIVES: Nonsmall cell lung cancer (NSCLC) is a multifactorial disease, and differences in the characteristics of surgical patientsmay develop over the years. This study aimed to evaluate the patients who underwent curative surgical resection for NSCLC in the past20 years at our center and analyze the changes in the treatment strategies based on demographics, surgical strategies, and histopathology.MATERIALS AND METHODS: In this retrospective single-center cohort study, 1995 patients who had undergone lobectomy, bilobectomy, or pneumonectomy for primary NSCLC from January 1997 to January 2017 were analyzed. Patients were divided into two groups:Group I included patients operated in the first 10 years and Group II included patients operated in the last 10 years.RESULTS: Overall, 77% of patients were operated in the last 10 years (458 vs. 1537 patients). Sleeve lobectomies performed in GroupII reduced the rate of pneumonectomy from 37% to 20% (p<0.001). The operation rates for adenocarcinomas increased significantlyduring the study period, increasing from 31.4% to 36.2% (p=0.049). The 30- and 90-day postoperative mortality rates were 4.6% and8.5% in Group I and 4.1% and 5.7% in Group II, respectively (p=0.69 and p=0.037, respectively). When the groups were compared, themedian and 5-year survival rates were 44.1 months (95% confidence interval [CI], 35.6–52.6) and 42.9% in Group I and 73.6 months(95% CI, 63.3–83.9) and 53.9% in Group II, respectively (p<0.001).CONCLUSION: This study demonstrates an improvement in long-term outcomes following lung cancer surgery with an increasing rateof surgical procedures in the last 10 years. There was an increase in the proportion of females affected and the rate of adenocarcinoma.However, the pneumonectomy and postoperative N2 disease rates have decreased with advancing preoperative evaluation techniquesand parenchyma-saving surgical methods. Postoperative mortality has decreased, and the survival rate has increased.

🔖

Bu Makaleye Atıf Yap

ÜÇVET, A., GÜRSOY, S., YAZGAN, S. (2020). Changes in the Surgical Treatment Strategies for Nonsmall Cell Lung Cancer in the Past 20 Years: A Single-Center Experience. Turkish Thoracic Journal, Cilt: 21 - Sayı: 1, 8–13. https://ajindex.com/articles/179521

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Uluşan A, Şanlı M, Işık AF, et al. Prognostic factors in operated T3 non-small cell lung cancer: A retrospective, single-center study of 129 patients. Turk Gogus Kalp Dama 2018
  2. [CrossRef] 2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015
  3. E359-86. [CrossRef] 3. Scaglia NC, Chatkin JM, Pinto JA, et al. Role of gender in the survival of surgical patients with nonsmall cell lung cancer. Ann Thorac Med 2013
  4. [CrossRef] 4. Turkey cancer statistics. Available at: http://kanser.gov.tr/Dosya/ ca_istatistik/2014-RAPOR._uzuuun.pdf. Accessed February 22,2018. 5. Melek H, Medetoğlu B, Demir A, et al. Mortality and morbidity after surgical treatment in elderly patients with non-small cell lung cancer: the role of age. Turkish J Thorac Cardiovasc Surg 2011
  5. [CrossRef] 6. Khullar OV, Liu Y, Gillespie T, et al. Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: an analysis from the national cancer data base. J Thorac Oncol 2015
  6. [CrossRef] 7. Roth K, Nilsen TIL, Hatlen E, et al. Predictors of long time survival after lung cancer surgery: A retrospective cohort study. BMC Pulm Med 2008
  7. [CrossRef] 8. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001
  8. [CrossRef] 9. Pfannschmidt J, Muley T, Bülzebruck H, et al. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Lung Cancer 2007
  9. [CrossRef] 10. Yıldız O, Cangır AK, Kılıç D, et al. Importance of SUVmax threshold in positron emission tomography-computed tomography assessment of mediastinal and hilar lymph nodes in nonsmall cell lung cancer. Turk Gogus Kalp Dama 2016
  10. [CrossRef] 11. Bozkurt B, Selçuk ZT, Fırat P, et al. Histological and epidemiological evaluation of patients with lung carcinoma between 1972 and 2002 in Hacettepe University Hospital. Turk Thorac J 2004
  11. Sulu E, Damadoğlu E, Nergiz S, et al. Does tumor type and sex distribution of primary lung cancer change? The comparison of the results of 2004 and previous years. Tuberk Toraks 2007
  12. Jassem J, Skokowski J, Dziadziuszko R, et al. Results of surgical treatment of nonsmall cell lung cancer: validation of the new postoperative pathologic TNM classification. J Thorac Cardiovasc Surg